Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
出版年份 2011 全文链接
标题
Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
作者
关键词
-
出版物
PHARMACOGENOMICS JOURNAL
Volume 12, Issue 6, Pages 476-483
出版商
Springer Nature
发表日期
2011-08-09
DOI
10.1038/tpj.2011.33
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Correlation of XPD gene with susceptibility to gastric cancer
- (2012) Chuan-Zhen Zhang et al. Chinese Journal of Cancer
- Powerful SNP-Set Analysis for Case-Control Genome-wide Association Studies
- (2010) Michael C. Wu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis
- (2010) Zheng Jiang et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of chemotherapy for patients with bone and soft-tissue sarcomas
- (2010) R. WESOLOWSKI et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
- (2010) J. Smida et al. CLINICAL CANCER RESEARCH
- Emerging drugs for high-grade osteosarcoma
- (2010) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Genome-Wide Association Studies of Cancer
- (2010) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study
- (2009) Hee Seung Kim et al. GYNECOLOGIC ONCOLOGY
- Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai
- (2009) Hui Wen et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- VEGF expression as a prognostic marker in osteosarcoma
- (2009) Jyoti Bajpai et al. PEDIATRIC BLOOD & CANCER
- Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
- (2009) Penelope A. Bradbury et al. Pharmacogenetics and Genomics
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies
- (2008) F. Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan
- (2008) Robert Nakayama et al. CANCER SCIENCE
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma
- (2008) James Doecke et al. INTERNATIONAL JOURNAL OF CANCER
- Relationship BetweenERCC1Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer
- (2008) Thomas C. Krivak et al. JOURNAL OF CLINICAL ONCOLOGY
- Susceptibility of XRCC3, XPD, and XPG Genetic Variants to Cervical Carcinoma
- (2008) Xiaohong He et al. PATHOBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started